Top

Gepubliceerd in:

2016 | OriginalPaper | Hoofdstuk

9. Antimicrobiële behandeling

Auteur : L. Abraham-Inpijn

Gepubliceerd in: Antibiotica en infecties

Uitgeverij: Bohn Stafleu van Loghum

Samenvatting

Het misbruik van antibiotica in de tandheelkunde loopt als een rode draad door de literatuu. De medicatie die door tandartsen wordt voorgeschreven bestaat in sommige landen voor 39% uit antimicrobiële middelen naast circa 44% pijnstilling. In ontwikkelingslanden bedraagt het percentage voorgeschreven antimicrobiële middelen zelfs 66 tot 82%. Meer kennis en betere regulering over en van antibiotica in de tandheelkunde is geen luxe.

vorige hoofdstuk Antimicrobieel scherm

volgende hoofdstuk Tandheelkunde en resistente micro-organismen

Cherry WR, Lee JY, Shugars DA, White RP Jr, Vann WF Jr. Antibiotic use for treating dental infections in children: a survey of dentists’ prescribing practices. J Am Dent Assoc. 2012;143(1):31–8.CrossRefPubMed

Dinsbach NA. Antibiotics in dentistry: bacteremia, antibiotic prophylaxis, and antibiotic missuse. Gen Dent. 2012;60(3):200–7.PubMed

Palmer NAO, Pealing R, Ireland RS, Martin MV. A study of therapeutic antibiotic prescribing in National Health Service general dental practice in England. Brit Dent J. 2000;188:554–8.PubMed

Sarkar C, Das B, Baral P. An audit of drug prescribing practices of dentists. Indian J Dent Res. 2004;1(2):58–61.

Ivancevic V, Perka C, Hasart O, Sandrock D, Munz DI. Imaging of low-grade bone infection with a technetium-99m labelled monoclonal anti-NCA-90 Fab’fragment in patients with previous joint surgery. Eur J Nucl Med Mol Imaging. 2002;29:547–51.CrossRefPubMed

Soulsby EJ. Resistance to antimicrobials in humans and animals. BMJ. 2005;331:1219–20.PubMedCentralCrossRefPubMed

Preshaw PM. Antibiotics in the treatment of periodontitis. Dent Update. 2004;31(8):448–50, 453–4, 456.PubMed

Oomens MA, Forouzanfar T. Antibiotic prophylaxis in third molar surgery: a review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(6):e5–12.CrossRefPubMed

Hallström H, Persson GR, Lindgren S, Olofsson M, Renvert S. Systemic antibiotics and debridement of peri-implant mucositis. A randomized clinical trial. J Clin Periodontol. 2012;39(6):574–81.CrossRefPubMed

10.

Calvo AM, Brozoski DT, Giglio FP, Gonçalves PZ, Sant’ana E, Dionísio TJ, Lauris JR, Santos CF. Are antibiotics necessary after lower third molar removal? Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(Suppl 5):199–208.CrossRef

11.

Adde CA, Soares MS, Romano MM, Carnaval TG, Sampaio RM, Aldarvis FP, Frederico LRT. Clinical and surgical evaluation of the indication of postoperative antibiotic prescription in third molar surgery. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(suppl 5):26–31.CrossRef

12.

Ellison SJ. An outcome audit of three day antimicrobial prescribing for the acute dentoalveolar abscess. Br Dent J. 2011;211(12):591–4.CrossRefPubMed

13.

Cadron A. Medicatiegebruik bij nierinsufficiëntie. Thesis 2012. Universiteit Leuven.

14.

Kasteren MEE van, Fennis JFM, Meer JWM van der. Rationeel antibioticagebruik door tandarts kan resistentie voorkomen. Ned Tijdschr Tandheelkd. 1997;104:3000–1.

15.

Ellison SJ. The role of phenxymethylpenicilline, amoxicilline, metronidazol and clindamycine in the management of acute dentoalveolar abscesses. A review. B Dent J. 2009;206(7):357–63.CrossRef

16.

González-Martínez R, Cortell-Ballester I, Herráez-Vilas JM, Arnau-de Bolós JM, Gay-Escoda C. Antibiotic prescription in the treatment of odontogenic infection by health professionals: a factor to consensus. Med Oral Patol Oral Cir Bucal. 2012;17(3):452–6.CrossRef

17.

Kuriyama T, Karasawa T, Nakagawa K, Nakamura S, Yamamoto E. Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics. Oral Microbiol Immunol. 2002;17(5):285–9.CrossRefPubMed

18.

SWAB. Mondbodemflegmone. Antibioticaboekje. Stichting werkgroep antibiotica beleid; 2014.

19.

Winkel EG, Van Winkelhoff AJ, Timmerman MF, Van der Velden U, Van der Weijden GA. Amoxicilline plus metronidazol in the treatment of adult periodontitis patients. J Clin Periodontol. 2001;28:296–303.CrossRefPubMed

20.

Barrett AP, Schifter M. Antibiotic strategy in orofacial/head and neck infections in severe neutropenia. Oral Surg Oral Med Oral Pathol. 1994;77(4):350–5.CrossRefPubMed

21.

Horning GM, Cohen ME. Necrotizing ulcerative gingivitis, periodontitis, and stomatitis: clinical staging and predisposing factors. J Periodontol. 1995;66(11);990–8.CrossRefPubMed

22.

Nguyen-Hieu T, Borghetti A, Aboudharam G. Peri-implantitis: from diagnosis to therapeutics. J Investig Clin Dent. 2012;3(2):79–94.CrossRefPubMed

23.

Borumandi F, Cascarini L. Peri-implantitis. Br J Oral Maxillofac Surg. 2012;50(8):689–94.CrossRefPubMed

24.

Zitzmann NU, Berglundh T. Definition and prevalence of peri-implant diseases. J Clin Periodontol. 2008;35(Suppl 8):286–91.CrossRefPubMed

25.

Javed F, Alghamdi AS, Ahmed A, Mikami T, Ahmed HB, Tenenbaum HC. Clinical efficacy of antibiotics in the treatment of peri-implantitis. Int Dent J. 2013;63(4):169–76.CrossRefPubMed

26.

Esposito M, Grusovin MG, Worthington HV. Treatment of peri-implantitis: what interventions are effective? A Cochrane systematic review. Eur J Oral Implantol. 2012;(Suppl 5):21–41.

27.

Romanos GE, Weitz D, Therapy of Peri-Implant Diseases. Where is the Evidence? J Evid Based Dent Pract. 2012;12:204–8.CrossRefPubMed

28.

Winkelhof AJ van. Antibiotics in the treatment of peri-implantitis. Eur J Oral Implantol. 2012;(suppl 5):43–50.

29.

Khammissa RA, Feller L, Meyerov R, Lemmer J. Peri-implant mucositis and peri-implantitis: clinical and histopathological characteristics and treatment. SADJ. 2012;67(3):122, 124–6.

30.

De Siena F, Francetti L, Corbella S, Taschieri S, Fabbro M Del. Topical application of 1 % chlorhexidine gel versus 0,2 % mouthwash in the treatment of peri-implant mucositis. An observational study. Int J Dent Hyg. 2013;11(1):41–7.CrossRefPubMed

31.

Wilder RS, Moretti AJ. Gingivitis and periodontitis in adults: classification and dental treatment. UpToDate Augustus; 2014.

32.

Winkelhoff AJ van. Problemen in de pocket: paropathogenen. Congres De Doelen, ‘De tand in al zijn facetten’. Rotterdam: Congres; 2009.

33.

Nethmap. Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. Jaarverslag; 2011.

34.

Patel M. The prevalence of beta lactamase-producing anaerobic oral bacteria in South African patients with chronic periodontitis. SADJ. 2011;66(9):416–8.PubMed

35.

Feres M, Haffajee AD, Allard K, Som S, Goodson JM, Socransky SS. Antibiotic resistance of subgingival species during and after antibiotic therapy. J Clin Periodontol. 2002;29(8):724–35.CrossRefPubMed

36.

Buchmann R, Muller RF, Van Dyke TE, Lange DE. Change of antibiotic susceptibility following periodontal therapy. A pilot study in aggressive periodontal disease. J Clin Periodontol. 2003;30(3):222–9.CrossRefPubMed

37.

Rodrigues RM, Gonçalves C, Souto R, Feres-Filho EJ, Uzeda M, Colombo AP. Antibiotic resistance profile of the subgingival microbiota following systemic or local tetracycline therapy. J Clin Periodontol. 2004;31(6):420–7.CrossRefPubMed

38.

Cionca N, Giannopoulou C, Ugolotti G, Mombelli A. Microbiological testing and outcomes of full-mouth scaling and root planing with or without Amoxicillin/Metronidazole in chronic periodontitis. J Period Online. 2010;82(1):15–23.CrossRef

39.

Goodson JM, Haffajee AD, Socransky SS, Kent R, Teles R, Hasturk H, Bogren A, Van Dyke T, Wennstrom J, Lindhe J. Control of periodontal infections: a randomized controlled trial I. The primary outcome attachment gain and pocket depth reduction at treated sites. J Clin Periodontol. 2012;39(6):526–36.CrossRefPubMed

40.

Zingale J, Harpenau L, Bruce G, Chambers D, Lundergan W]. The effectiveness of scaling and root planing with adjunctive time-release minocycline using an open and closed approach for the treatment of periodontitis. Gen Dent. 2012;60(4):300–5.PubMed

41.

Zijnge V, Ammann T, Thurnheer T, Gmür R. Subgingival biofilm structure. Rev Front Oral Biol. 2012;15:1–16.CrossRef

42.

Jain N, Lai PC, Walters JD. Effect of gingivitis on azithromycin concentrations in gingival crevicular fluid. J Periodontol. 2012;83(9):1122–8.PubMedCentralCrossRefPubMed

43.

American dental association counsil on scientific affairs. Combating antibiotic resistance. 1: J Am Dent Assoc. 2004;135(4):484–7. (Erratum in: J Am Dent Assoc. 2004;135/6:727.)

44.

Ogunbododo EO, Fatusi OA, Folayan MO, Olayiwola G. Retrospective survey of antibiotic prescriptions in dentistry. J Contemp Dent Pract. 2005;6(2):1–7.

45.

Larsen T. Susceptibility of Porphyromonas gingivalis in biofilms to amoxicillin, doxycycline and metronidazole. Oral Microbiol Immunol. 2002;17(5):267–71.CrossRefPubMed

46.

Collaert B, Bruyn H de. Zijn antimicrobiële middelen effectief tegen parodontitis? NTvT. 2002;109:444–8.

47.

Peedikayik FC. Antibiotics: use and misuse in pediatric dentistry. (Review). J Indian Soc Ped. 2011;29(4):282–7.CrossRef

48.

Aljateeli M, Giannobile WV, Wang HL. Locally-delivered antibiotics for management of periodontitis: current understanding. J Mich Dent Assoc. 2013;95(7):42–47.PubMed

49.

Tozum TF, Yildirim A, Caglayan F, Dincel A, Bozkurt A. Serum and gingival crevicular fluid levels of ciprofloxacin in patients with periodontitis. J Am Dent Assoc. 2004;135(1):1728–32.CrossRefPubMed

50.

Redactioneel. Zorginstituut Nederland. Antimicrobiële middelen; 2014.

51.

Pavicić MJ, Winkelhoff AJ van, Douqué NH, Steures RW, Graaff J de. Microbiological and clinical effects of metronidazole and amoxicillin in Actinobacillus actinomycetemcomitans-associated periodontitis. A 2-year evaluation. J Clin Periodontol. 1994;21(2):107–12.CrossRefPubMed

52.

Ratka-Kruger P, Schacher B, Burklin T, Boddinghaus B, Holle R, Renggli HH, Eickholz P, Kim TS. Non-surgical periodontal therapy with adjunctive topical doxycycline: a double-masked, randomized, controlled multicenter study. II. Microbiological results. J Periodontol. 2005;76(1):66–74.CrossRefPubMed

53.

Screenivasan P, Gaffar A. Antiplaque biocides and bacterial resistance: a review. J Clin Periodontol. 2002;29(11):965–74.CrossRef

54.

Menendez A, Li F, Michalek SM, Kirk K, Makhija SK, Childers NK. Comparative analysis of the antibacterial effects of combines mouthrinses on Streptococcus mutans. Oral Microbiol Immunol. 2005;20(1):31–34.CrossRefPubMed

55.

Meurman JH. Probiotics: do they have a role in oral medicine and dentistry? Eur J Oral Sci. 2005;113(3):188–96.CrossRefPubMed

56.

Sugano N. Biological plaque control: novel therapeutic approach to periodontal disease. J Oral Sci. 2012;54(1):1–5.CrossRefPubMed

57.

Van Zundert M. Antibiotica vaak overbodig voor koortsige kankerpatiënten. Diagned 2006; maart: 20–21.

58.

Urbonas V, Eidukaitė A, Tamulienė I. The diagnostic value of interleukin-6 and interleukin-8 for early prediction of bacteremia and sepsis in children with febrile neutropenia and cancer. J Pediatr Hematol Oncol. 2012;34(2):122–7.CrossRefPubMed

59.

Oude Nijhuis C, Kamps WA, Daenen SM, Gietema JA, Graaf WT van der, Groen HJ, Vellenga E, Vergert EM Ten, Vermeulen KM, Vries-Hospers HG de, Bont ES de. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients. J Clin Oncol. 2005;23(30):7437–44.CrossRefPubMed

60.

Stokman MA, Oude Nijhuis CS, Spijkervet FK, Bont ES de, Dijkstra PU, Daenen SM, Gietema JA, Graaf WT van der, Groen HJ, Vellenga E, Kamps WA. The role of oral mucositis on the systemic inflammation parameter IL-8 in febrile neutropenic cancer patients. Cancer Invest. 2006;24(5):479–83.CrossRefPubMed

Titel: Antimicrobiële behandeling
Auteur: L. Abraham-Inpijn
Uitgeverij: Bohn Stafleu van Loghum
Boek: Antibiotica en infecties
Print ISBN: 978-90-368-0541-4

Elektronisch ISBN: 978-90-368-0542-1

Copyright: 2016
DOI: https://doi.org/10.1007/978-90-368-0542-1_9

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen